author-photo

Ivan Sokirniy

14

Papers

101

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Abstract A206: Small-molecule Cbl-b inhibitors as novel intracellular checkpoint inhibitors for cancer immunotherapy

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (2)
USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T cell leukemia

2018
Show All
- Source
- Cite
- Save
Citations (1)
Abstract B193: Characterization of selective active-site targeted covalent inhibitors of usp7

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (0)
USP7 cooperates with NOTCH1 to drive the oncogenic transcriptional program in T cell leukemia

2018 bioRxiv
Show All
- Source
- Cite
- Save
Citations (1)
Abstract B202: Covalent irreversible usp7 inhibitors for cancer immunotherapy

2018 Molecular Cancer Therapeutics
Show All
- Source
- Cite
- Save
Citations (1)
Active site-targeted covalent irreversible inhibitors of USP7 impair the functions of Foxp3+ T-regulatory cells by promoting ubiquitination of Tip60

2017 PLOS ONE
Show All
- Source
- Cite
- Save
Citations (29)
Abstract 5336: Characterization of selective covalent inhibitors of USP7

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 1691: USP7 inhibitors impair Foxp3+ T regulatory cell function and promote antitumor immunity against solid tumors

2017 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract 559: Small molecule T-reg inhibitors for cancer immunotherapy

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract 2228: Cbl-b inhibitors as novel intra-cellular checkpoint inhibitors for cancer immunotherapy

2016 Cancer Research
Show All
- Source
- Cite
- Save
Citations (2)